Test Price
2,800 AED✅ Home Collection Available
SLCO2A1 Gene Hypertrophic Osteoarthropathy Type 2 Genetic Test | 2,800 AED
Executive Summary & Core Metrics
Core Test Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM.
- Clinical Guidance: Telephonic post-test clinical guidance from DHA-licensed Consultant Medical Genetics.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced Next-Generation Sequencing (NGS) test examines the entire coding region of the SLCO2A1 gene to identify pathogenic variants causing primary hypertrophic osteoarthropathy type 2 (PHOAR2). With a 99.9% analytical sensitivity, it provides definitive molecular confirmation for inherited digital clubbing, periostosis, and dermatological manifestations, enabling accurate family risk assessment and proactive management.
| Feature | Our SLCO2A1 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next-Generation Sequencing (full gene + CNV analysis) | Sanger sequencing of coding exons only |
| Diagnostic Sensitivity | 99.9% (detects SNVs, indels, and large deletions/duplications) | ~95% (misses deep intronic variants and large rearrangements) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Coverage | 100% of coding region ±10 bp intronic boundaries | >98% of coding region, no CNV detection |
Physician Insight & Safety Protocols
Insight from Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403): A positive SLCO2A1 genetic result confirms hereditary predisposition but must be interpreted alongside your full clinical history—clubbing, bone pain, and skin changes. Early molecular diagnosis empowers families with knowledge and triggers appropriate surveillance. Please continue all prescribed medications; this test clarifies etiology but never replaces your physician’s ongoing care.
Advisory Notes
Do not discontinue prescribed medication without consulting your doctor. The test is intended for diagnostic confirmation and does not alter existing treatment regimens.
Exclusion Criteria & ER Red Flags
- Sample rejection if tube is damaged, clotted, or insufficient volume.
- Not designed for acute crisis; patients with sudden severe bone pain, rapidly worsening digital clubbing, or respiratory distress must seek immediate medical attention.
- Pregnancy or recent blood transfusion does not invalidate DNA test but should be disclosed during pre-test counselling.
Patient FAQ & Clinical Guidance
1. What is the SLCO2A1 gene test used for?
The SLCO2A1 gene test diagnoses primary hypertrophic osteoarthropathy type 2, an inherited disorder causing digital clubbing, periostosis, and skin thickening. It confirms the molecular cause for family risk assessment and management.
2. How is the sample collected for this test?
A simple blood draw, one drop of blood on an FTA card, or pre-extracted DNA is collected at home by a DHA-licensed phlebotomist using cold-chain transport. The VIP Mobile Phlebotomy service is available daily from 8 AM to 11 PM.
3. How long do results take and will a doctor explain them?
Results are available within 3–4 weeks due to comprehensive NGS analysis and thorough bioinformatics interpretation. A DHA-licensed Consultant Medical Genetics will discuss the results with you telephonically.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is handled with explicit informed consent, and the laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | SLCO2A1 Gene Hypertrophic Osteoarthropathy Type 2 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood, FTA card, or pre-extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV analysis |
| ICD-10-CM Code | M89.40 |
| LOINC Code | 76002-6 |
| DHA Facility License & Laboratory Address | License No. 1143 • Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE • DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians